Ribonucleotide Reductase Subunit Switching in Hepatoblastoma Drug Response and Relapse
L. Zhu, A. Brown, Q. Pan, L. Fan, E. Indersie, C. Tian, N. Timchenko, L. Li, B. S. Hansen, H. Tan, M. Lu, J. Peng, S. M. Pruett-Miller, J. Yu, S. Cairo
This study identifies RRM2 and RRM2B as key players in hepatoblastoma progression and drug response, showing their dynamic switching and impact on relapse.
bioRxiv · Jan 24, 2023Cancer Biology